AS

Arun Singh

Active Director Director DIN 09032561
DIN 09032561 First appointment Feb 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Arun Singh

Data last updated:

Arun Singh is a Director at Subh Parenteral Private Limited (since 2021). The company operates in Healthcare. Subh Parenteral Private Limited reported revenue of ₹77,178 (FY 2023).

DIN 09032561
Primary Designation Director
Industry Healthcare
First Appointment 03 Feb 2021
Oldest Company Age 5 yrs
Largest company Subh Parenteral Private Limited · ₹77,178 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Subh Parenteral Private Limited U24233UP2021PTC141159
Director03 Feb 20212021₹77,178 (FY 2023)Active

Board colleagues of Arun Singh

Directorship timeline

Open interactive timeline →
Subh Parenteral Private Limited
Premium access

Shareholding and investment profile for Arun Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Singh

Arun Singh currently holds 1 directorship: Subh Parenteral Private Limited (Director, since 03 Feb 2021, revenue ₹77,178 (FY 2023)).

Arun Singh was first appointed on 03 Feb 2021 as Director at Subh Parenteral Private Limited.

The current boards of Arun Singh's companies include Atul Agrawal (Subh Parenteral Private Limited), Sanjay Maheshwari (Subh Parenteral Private Limited), Vineet Kela (Subh Parenteral Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available